Dupont Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-631	Closed	-$518K	–	692
2023 Q1	$518K	Sell	631 -631	-50%	-$476K	0.02%	316
2022 Q4	$911K	Sell	1,262 -575	-31%	-$424K	0.04%	398
2022 Q3	$1.26M	Buy	1,837 +95	+5%	+$59.8K	0.08%	294
2022 Q2	$1.03M	Sell	1,742 -10	-0.6%	-$6.5K	0.05%	409
2022 Q1	$1.22M	Sell	1,752 -1,680	-49%	-$1.06M	0.05%	406
2021 Q4	$2.17M	Sell	3,432 -609	-15%	-$374K	0.08%	239
2021 Q3	$2.45M	Sell	4,041 -1,002	-20%	-$622K	0.08%	265
2021 Q2	$2.82M	Buy	5,043 +1,350	+37%	+$684K	0.07%	263
2021 Q1	$1.75M	Sell	3,693 -1,080	-23%	-$526K	0.04%	392
2020 Q4	$2.31M	Sell	4,773 -325	-6%	-$175K	0.05%	299
2020 Q3	$2.85M	Buy	5,098 +280	+6%	+$170K	0.06%	239
2020 Q2	$3M	Buy	4,818 +933	+24%	+$530K	0.07%	226
2020 Q1	$1.9M	Buy	3,885 +818	+27%	+$337K	0.05%	307
2019 Q4	$1.15M	Buy	3,067 +1,756	+134%	+$591K	0.03%	531
2019 Q3	$364K	Hold	1,311	–	–	0.01%	914
2019 Q2	$410K	Hold	1,311	–	–	0.01%	870
2019 Q1	$538K	Hold	1,311	–	–	0.01%	733
2018 Q4	$490K	Buy	1,311 +345	+36%	+$126K	0.01%	739
2018 Q3	$390K	Buy	+966	New	+$368K	0.01%	758
2018 Q1	–	Sell	-481	Closed	-$181K	–	1005
2017 Q4	$181K	Buy	481 +94	+24%	+$38.1K	﹤0.01%	794
2017 Q3	$173K	Sell	387 -60	-13%	-$28.6K	﹤0.01%	819
2017 Q2	$220K	Buy	+447	New	+$196K	﹤0.01%	807